Salwa Mansour
808 Route De Lennik
Brussels, BRU 1070, Belgium
Brussels, BRU 1070, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
Journal: Acta neuropathologica
Published: April 15, 2024
de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia.
Journal: Acta neuropathologica communications
Published: May 11, 2020
The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: April 30, 2020
Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice.
Journal: Frontiers in molecular neuroscience
Published: March 24, 2020
Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Journal: Acta neuropathologica
Published: September 13, 2019
Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
Journal: Acta neuropathologica
Published: November 29, 2018
A 4R tauopathy develops without amyloid deposits in aged cat brains.
Journal: Neurobiology of aging
Published: November 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026